Abstract. Cyclin-dependent kinase 5 (cdk5) is a serine/threonine kinase that, when activated, induces neurite outgrowth. Recent in vitro studies have shown that cdk5 phosphorylates tau at serine 199, serine 202, and threonine 205 and that p25, an activator of cdk5, is increased in Alzheimer disease (AD). Since tau is hyperphosphorylated at these sites in neurofibrillary tangles, we examined brain tissue from patients with AD and normal elderly control cases to determine whether cdk5 and these phosphoepitopes colocalize in neurofibrillary tangles. Adjacent temporal lobe sections were double immunostained with a polyclonal anti-cdk5 and monoclonal AT8 (which recognizes phosphorylated serine 199, serine 202, and threonine 205 in tau) antibodies. A subset of AT8 phosphotau-positive neurons was immunoreactive for cdk5 in entorhinal (area 28) and perirhinal (area 35) cortices and CA1 of the hippocampus. We assessed the ratio of cdk5-positive cells to AT8-positive cells and found that there is a higher degree of colocalization in pre-neurofibrillary tangles as opposed to intraneuronal and extraneuronal neurofibrillary tangles. We further examined colocalization using fluorescence resonance energy transfer. This suggests a close, stable intermolecular association between cdk5 and phosphorylated tau, consistent with phosphorylation of tau by cdk5 in AD brain.
INTRODUCTION
Neurofibrillary tangles (NFTs) and senile plaques (SPs) are the key pathological lesions in Alzheimer disease (AD). NFTs and neuronal loss are strongly correlated to duration and severity of dementia (1) . In the normal adult human brain, tau is minimally phosphorylated and is a microtubule-associated protein that acts to stabilize microtubules. The paired helical filaments of neurofibrillary tangles are formed primarily of abnormally phosphorylated tau (2) (3) (4) (5) (6) (7) . This lesion is thought to obstruct normal cell function, eventually causing neuronal death.
There are several types of kinases that phosphorylate tau in vitro. Proline directed kinases including cyclindependent kinase 5, mitogen-activated protein kinase, and glycogen synthase kinase-3␤ phosphorylate tau at serine or threonine sites adjacent to prolines. Nonproline directed kinases, such as microtubule affinity regulating kinase and phosphorylation kinase A appear to play a lesser role in NFT-associated phosphorylation. Recent in vitro studies have shown that cdk5 phosphorylates tau at sites serine 202 and threonine 205 and that p25, an activator of cdk5, is increased in AD (8) (9) (10) , suggesting that cdk5 may be constitutively activated. We therefore examined the hypothesis that cdk5 play a prominent, and possibly early, role in NFT formation.
MATERIALS AND METHODS

Subjects
Subjects were selected from the Alzheimer's Disease Research Center Brain Bank at Massachusetts General Hospital in Boston, Massachusetts. Fourteen total cases were studied (Table). Diagnoses were established using a standard protocol relying on use of 19 cortical and subcortical frozen blocks (11) . Of those 14 cases, 10 had AD (4 males/6 females; age at death 84.1 Ϯ 9.1 yr (mean Ϯ SD), range 65-100 yr, n ϭ 9) (NIAReagan criteria and CERAD) (11-13), 2 cases had dementia with Lewy bodies (DLB) (consensus DLB criteria) (14) (2 males; age at death 82.5 Ϯ 2.1 yr, range 81-84), and 2 were control cases (1 male/1 female; age at death 88 Ϯ 22.6 yr, range 72-104). For the AD cases, the average duration of illness was 11.1 Ϯ 5.0 yr (range 4-20 yr, n ϭ 8) and average postmortem interval was 12.7 Ϯ 5.5 h (range 9-26 h, n ϭ 8). For the DLB cases, the average duration of illness was 3.5 Ϯ 2.1 yr (range 2-5 yr) and average postmortem interval was 14.5 Ϯ 6.4 h (range 10-19 h). The average postmortem interval for the control cases was 20.3 h (range 16-24.5 h). All of the AD cases had a clinical history of cognitive dysfunction, and all met the neuropathological criteria of AD with amyloid plaques and neurofibrillary tangles (12) . Braak and Braak stages for the AD cases ranged between III and VI (15) . One of the AD cases had concurrent cortical LB, as well. The DLB cases satisfied the neuropathological criteria for the neocortical type of DLB (14, 16) . Neither of the control cases had a clinical history of cognitive impairment or neurological disorder. The control tissue contained very few scattered plaques and tangles and did not meet criteria for AD.
Tissue Processing
For this study, we used tissue from the temporal lobe containing the amygdala, hippocampal formation, and the adjacent temporal neocortex. The temporal blocks were fixed in periodate-lysine-paraformaldehyde (PLP) for 2 days, transferred to 15% glycerol in tris-buffered saline (TBS, pH 7.4), serial sectioned at 50 m on a freezing microtome, and cryoprotected in the 15% glycerol solution. Sections were then stored at Ϫ20ЊC for future immunohistochemical experiments.
Immunohistochemistry
Sections from each case were separately stained with a rabbit antibody cdk5 against full-length human cdk5 (1:200, Santa Cruz, Santa Cruz, CA) and a monoclonal antibody AT8 against human PHF-tau (1:100, Innogenetics, Ghent, Belgium). Sections were first incubated in 0.5% Triton-X in 3% hydrogen peroxide for 20 min and then washed 3 times in 1X TBS. The tissue was then blocked in 3% milk in TBS for 1 h. Following 2 washes in TBS, the sections were allowed to incubate with the primary antibody overnight at 4ЊC on a shaker table. Negative control sections were incubated in 1.5% normal goat serum in TBS instead of with the primary antibodies. A biotinylated goat anti-rabbit secondary (Jackson ImmunoResearch, West Grove, PA) followed by streptavidin-peroxidase (Vectastain Elite ABC kit, Vector Labs, Burlingame, CA) was applied to the sections labeled with cdk5 while the AT8 sections were labeled with a horseradish peroxidase goat anti-mouse secondary (Jackson ImmunoResearch). Immunostaining was developed with diaminobenzidine/H 2 O 2 . Tissue was mounted on slides, dried, dehydrated through increasing concentrations of ethanol and xylenes, and coverslipped with Permount.
Sections from all cases were also double stained using fluorescence immunohistochemistry with the polyclonal rabbit cdk5 and monoclonal AT8 primary antibodies. The fluorescence immunohistochemistry followed the same initial procedure as the single staining described above except that sections were first washed in a 0.5% Triton-X in 1X TBS solution instead of in 0.5% Triton-X in 3% H 2 O 2 . After the tissue was incubated overnight in the primary antibodies, a biotinylated goat anti-rabbit secondary followed antibody by streptavidin Cy3 (Jackson ImmunoResearch) was used to label the cdk5 and a fluoresceinlabeled goat anti-mouse secondary antibody (Molecular Probes, Eugene, OR) was used to mark the PHF-tau deposits. The mounted tissue was allowed to air-dry rather than dry on a slide warmer. Negative controls for the double immunofluorescent staining were 1) omitting the primary antibody and 2) reversing the secondary antibodies. In both instances the staining was negative.
Quantitation and Data Analysis
Double immunofluorescent tissue stained for cdk5 and AT8 were quantified with random sampling stereological methods and optical dissector using a Bioquant Image Analysis System with Stereology Package (Nashville, TN). The Bioquant software was run on an Arbor PC computer attached to a Leica DMRB microscope connected to a MTI 3CCD camera. Entorhinal cortex (area 28), perirhinal cortex (area 35), and CA1 in the hippocampus were anatomical regions of interest in the current study. With the Bioquant Software, a random sampling grid with counting boxes applied at regular intervals was superimposed on the region of interest. Neurons and neuropil threads were counted in the same manner. The counting boxes were 100 ϫ 100 m 2 with extended exclusion lines. An average of 200 counting boxes were assessed per case and 2 slides per case were used.
Fluorescence Resonance Energy Transfer (FRET)
For fluorescence resonance energy transfer (FRET) experiments, immunostaining was observed using a Bio-Rad MRC-1024 confocal microscope mounted on a Nikon TE400 inverted microscope. The krypton-argon laser was used to excite fluorescein (excitation 488) and Cy3 (excitation 568). The energy transfer was detected as an increase in donor fluorescence following photobleaching of the acceptor fluorescence (i.e. donor dequenching) (17) (18) (19) . The FRET data are represented as a percentage increase in donor fluorescence after photobleaching of the acceptor fluorescence that were corrected for background fluorescence. Four scans were saved from the confocal microscope for the FRET experiment. box was outlined on a cdk5-Cy3-positive neuron and this area was photobleached completely with 568 nm light, with the laser power at 30%. After thorough photobleaching to destroy the acceptor molecule, the magnification was returned to original zoom magnitude and re-scanned with the 568 line with (ϳ1% power) to confirm that photobleaching was effective. Finally, the neuron was scanned after the photobleaching with the 488 line (ϳ1% power). FRET is detected as an increase in brightness of the FITC signal within the region where the acceptor dye, Cy3, had been photobleached. Negative controls included ''sham'' photobleaching single labeled sections: after exposure of FITC single label sections to intense 568 laser light, no change in FITC fluorescence was detected.
A Student t-test was used to test the significance of the increase in FRET. To compare the means of increased FRET among pretangles and intraneuronal and extraneuronal NFTs (iNFTs/eNFTs), a one-way ANOVA was used. The significance level was set at p Ͻ 0.05.
RESULTS
AT8 Immunostaining in Temporal Cortices in the Human Brain
AT8 is a monoclonal antibody directed against several epitopes on the tau molecule; it detects phosphorylated serine 199, phosphorylated serine 202, and phosphorylated threonine 205 (20) . AT8 densely stains NFTs in the human brain, particularly in the temporal lobe. AT8 predominantly stains iNFTs and eNFTS; nonetheless, preNFTs, which are phosphotau-immunopositive but do not contain filamentous tau, are also observed. Additionally, it stains NFTs in the pyramidal layer of CA1 of the hippocampus and layer II in entorhinal cortex and to a lesser extent entorhinal layers III and IV. The nomenclature of Lorente de No was followed in this study (21) . In perirhinal cortex layers II and III are robustly stained. AT8 also stained multiple neurons in the temporal neocortical areas 36, 20, 21, and 22. Area 22, located in the superior temporal gyrus, contained the least amount of AT8 immunoreactivity in temporal neocortices. These results parallel previous analyses of NFT distribution (22) . AT8 also labels neuropil threads throughout the temporal cortex. The pattern of immunoreactivity of AT8 is similar to that of PHF-1 and Alz-50 (23, 24) , suggesting that the same populations of vulnerable neurons are stained with each.
In the DLB cases, NFTs were observed in the same anatomical areas as in the AD cases, however, the density of NFTs was less and the immunoreactivity was limited to layer II in entorhinal cortex, layers II and III in perirhinal cortex and CA1 in the hippocampus. Other sparse immunostaining was noted throughout the temporal neocortex. The age-matched control brains also contained NFTs that were immunoreactive for AT8 but were observed only in entorhinal and perirhinal cortex in layer II. These cases did not meet NIA-Reagan or CERAD criteria for possible AD (11-13).
Cdk5 Immunostaining
The cdk5 antibody is a rabbit polyclonal antibody that is directed against full-length human cdk5. Cdk5 staining was found in numerous pyramidal neurons, including the anatomical populations vulnerable for NFT in AD, DLB, and aged control brains. Cdk5 staining was observed in all layers of the entorhinal, perirhinal, and hippocampal areas and in addition layers II, III, and V of the cortex. Cdk5 immunostaining in entorhinal cortex layer II in AD and control brains is shown in Figure 1 .
Colocalization of cdk5 and AT8
Our previous data suggest that neurons go through stages during the development of an NFT that correlate with specific phospho-epitopes: pre-neurofibrillary tangles, iNFTs, and eNFTs (25) . We examined the relationship between cdk5 staining and these morphological classifications of NFT. Initially in the development of an NFT, neurons labeled with specific phospho-tau antibodies displayed punctate regions that resemble speckles distributed throughout the cytoplasm of the neuron. Morphologically, these neurons show normal dendritic processes, while cell somas were broad and distinct nuclei and nucleoli were observed. Pre-NFTs contain no fibrillar tau. An example of a pre-NFT colocalized cdk5 and AT8 and the respective fluorescent secondary markers, Cy3 and fluorescein, is shown in Figure 2A , B. iNFTs contain aggregates of fibrillar tau. The dendrites of neurons containing iNFTs appear to deteriorate and the intraneuronal inclusions of tau appear more homogeneous than in the previous stage, no longer displaying the speckled punctate regions. These types of NFT (Fig. 2D ) also stain with cdk5 (Fig. 2C) . eNFTs are largely filamentous collections of PHF, do not contain cell components, nuclei, and do not stain for rough endoplasmic reticulum or ribosomes. The dendrites of eNFTs are absent and eNFTs have numerous dystrophic neurites, or neuropil threads, surrounding them. An eNFT is a marker of a once viable neuron, often called a tombstone NFT. Surprisingly, some eNFTs (Fig. 2F ) also stain for cdk5 (Fig. 2E) . DAPI (4Ј,6-diamidino-2-phenylindole) staining was used to detect nuclei; the presence or absence of nuclear staining was used to confirm the assessment of iNFT and eNFT (26) .
We next quantitated the extent of colocalization of cdk5 staining with AT8-immunopositive NFT in different regions using a stereological sampling approach to randomly select microscopic fields within each brain area for analysis. The colocalization percentages are followed by the raw numbers of neurons colocalized in parentheses. In the entorhinal and perirhinal cortices, 67% (8/12) of AT8-positive pre-NFTs were also cdk5-immunoreactive. iNFTs in entorhinal cortex colocalized cdk5 and AT8 only 29% (31/106) of the time. Surprisingly, 26% (19/72) of eNFTs in the entorhinal cortex showed cdk5 and AT8 colocalization. Similarly, 27% (707/2653) of the neuropil threads (NTs) in the entorhinal and perirhinal cortices showed colocalization of cdk5 and AT8. Thus, in these cortical areas, cdk5 colocalization with AT8 was higher in pre-NFTs than in eNFTs and iNFTs.
No pre-NFTs were observed in the hippocampal area CA1 in the subpopulation of the randomly selected neurons examined; cdk5 neurons colocalized with AT8ϩ iNFTs at 18% (3/17), while cdk5 colocalization was less common for eNFTs at 8% (2/25) in the CA1 field of the hippocampus. NTs showed cdk5 and AT8 colocalization similar to the amount seen in iNFTs.
When data are summed across the 3 regions examined, we find that AT8 immunoreactive pretangles showed 67% colocalization with cdk5, iNFTs showed 29% colocalization, eNFTs showed 22% colocalization, and NTs showed 43% colocalization. Taken together, the data show that a subset of AT8ϩ neurofibrillary lesions are cdk5-positive. Although the exact relationship varied slightly according to the morphologies of NFT in different anatomical areas, overall it appears that pre-NFT are more likely to be cdk5 stained than either iNFT or eNFT.
FRET between cdk5 and AT8
Co-staining by confocal microscopy suggests that 2 epitopes are within the limits of resolution of the technique, which is on the order of the wavelength of light used (500 nm). We next studied AT8/cdk5 interactions using FRET, a biophysical technique that provides information on the distance between molecules. Using indirect immunofluorescence, FRET can only be detected if the proteins are less than approximately 30-50 nm apart (18, 27) . FRET cannot be detected if the fluorophores are greater than this distance apart and the amount of FRET detected increases in proportion to decreasing distance between fluorophores.
Using FRET, we examined 33 NFTs that showed colocalization and found a significant mean increase (11%) in donor fluorescence (p Ͻ 0.05, compared to an expected value of 0 in the absence of FRET). There was considerable variation in the amount of FRET in different NFTs, with several neurons showing an increase in donor fluorescence on the magnitude of 45%-61% (Fig. 3) , while others showed very little. We reviewed the morphological subtypes of the NFTs examined and found that NFTs with the largest amount of FRET were observed in pre-NFTs (Fig. 4 ). There were no statistically significant differences observed in the amount of FRET between cdk5 and AT8 in different morphological subtypes, although the sample size for this secondary analysis may not have been adequate to detect modest differences. The presence of FRET interactions in extracellular tangles demonstrates that the cdk5-NFT colocalization is not due to cdk5 in processes from glial cells surrounding eNFT (because a membrane introduces a barrier to FRET), but instead supports the idea that there are tight cdk5-tau interactions even in eNFT.
DISCUSSION
Abnormally phosphorylated tau is the main component in PHFs, and thus, NFTs in AD (2-6). There are several kinases that phosphorylate tau in vitro, including MAPK, GSK3␤, MARK, PKA, and cdk5 (28) (29) (30) (31) (32) (33) (34) (35) , and colocalization of MAPKp38 and PHF has been shown in AD (18, 36, 37) . Nevertheless, the extent to which these participate in tau phosphorylation in AD, and the order in which they act, remain difficult to ascertain. We have examined different morphological subtypes of NFT that represent a hierarchical set of changes and asked if the association of cdk5 with NFT obeyed hierarchical rules.
In this study, we show that AT8 and cdk5 colocalize in some NFTs in AD. This suggests that cdk5 may be present during the formation of a neurofibrillary tangle. When AT8 and cdk5 are examined independently, neurons that are cdk5-positive tend to be ''pretangle'' NFTs, whereas neurons that are AT8-positive more likely contain fibrillar intra-neuronal lesions. Of the areas examined, the entorhinal and perirhinal cortices displayed the (A, B) is an example of a pretangle because it has retained its multiple dendrites and exhibits no cellular atrophy. The neuron in (C, D) is an example of intraneuronal neurofibrillary tangle (iNFT) because it also contains stainable cytoplasm, but its cell shape and neurites are slightly deteriorated, while the neuron in (E, F) is an example of an extraneuronal neurofibrillary tangle (eNFT) that contains no stainable cytoplasm but was cdk5-positive. All of these cell types colocalize with cdk5. highest density of cdk5/AT8 colocalization in pre-NFTs. Since NFTs are first observed in perirhinal cortex (15) , and there is a high colocalization in the NTs in this area, this could suggest that an even earlier change in perirhinal cortex and AD is occurring at the dendritic level. Our results provide further evidence that cdk5 is present in NFTs and that there is an in vivo interaction with tau in AD.
The closeness of the interaction between AT8 and cdk5 was measured by FRET. FRET is a sensitive technique that can detect protein-protein interactions (17, 18) . Our previous studies show that presence and amount of FRET can even distinguish the closeness of interactions between N and C termini of interacting molecules (19) . Thus, we interpret the current results to strongly support a close interaction between tau with NFTs and cdk5. This FRET , iNFTs were 5% (n ϭ 11), and eNFTs were 9.5% (n ϭ 8).
result suggests a close, stable intermolecular association between cdk5 and pSer 199 , pSer 202 , and pThr 205 that is consistent with phosphorylation of tau at these sites by cdk5 and the formation of a relatively stable enzyme-substrate complex. Surprisingly, even some eNFTs retain cdk5 immunoreactivity.
These studies are consistent with previous observations showing staining of NFT by MAPK and that activated MAPK shows FRET with phosphorylated serine 396 (18, 36, 37) . Additionally, MARK stains some NFTs and shows FRET with phosphorylated serine 262 (18) , and activated GSK3␤ also stains a subset of NFT (30) . Together these data suggest that tau acts as a substrate for multiple kinases in vivo and that NFTs can sequester various kinases. Our current data showing that ''pre-NFT'' are frequently associated with cdk5 suggests that cdk5 may act at an early stage in NFT formation. On the other hand, FRET observations indicate a close intermolecular association between cdk5 and tau and cdk5 immunoreactivity even with (some) extracellular NFTs. This suggests that cdk5 and tau form a stable complex that may be active throughout the life history of a tangle.
